Loading…
← CockpitCompetitor Analysis › 603077.SS Sichuan Hebang Biotechnology Co. Ltd. Class AOpen in the cockpit ↗

Sichuan Hebang Biotechnology Co. Ltd. Class A603077.SSCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Agricultural

Chinese chemical producer of soda ash, calcium chloride and agrochemical/pesticide intermediates such as glyphosate-related chemicals.

Momentum weak 29
Mkt cap
$2.59B
US dollars, full cap
Free float
61%
of shares outstanding
$/day
$27.2M
20-day average traded
P/B
0.89×
price to book
ROE
-0.9%
delivered
Implied ROE
8.1%
what the price asks
Next earnings
172 days
27 Apr 2027
Close · CNYCN¥2.06
1D-1.4%
1W+3.0%
1M-5.9%
3M-13.8%
6M-30.4%
YTD-8.8%
1Y-2.8%
ATR %2.7%
52w lowhigh41.8% off high

What Sichuan Hebang Biotechnology does

Chinese chemical producer of soda ash, calcium chloride and agrochemical/pesticide intermediates such as glyphosate-related chemicals.

Products and services

  • Soda ash (sodium carbonate)
  • Glyphosate/pesticide intermediates
  • Calcium chloride

Customers

  • Glass/detergent manufacturers
  • Agrochemical companies

Where it sits in the supply chain

  • Materials
  • Basic & agricultural chemicals
  • Soda ash & pesticide intermediates

What could go right

  • Soda ash/glass demand
  • Glyphosate export demand

What could go wrong

  • Commodity chemical price cycles

Moat: none. Commodity bulk-chemical producer competing largely on cost/scale.

Headquarters: Chengdu, China · Employees: 5,085

Named competitors

Sichuan Hebang Biotechnology at a glance

Size Sichuan Hebang Biotechnology (603077.SS) is a China Materials company (Chemicals: Agricultural) with a market value of $2.59B, the 1001st largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥2.06 on 6 Nov 2026.

Performance Over six months the shares fell 30.4%, against -25.1% for the median peer and -16.4% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.

Growth Revenue fell 24.1% over the last twelve months (peer median +5.9%); the operating margin is -1.2% (peer median 12.2%).

Valuation It trades at 0.89× book value against a peer median of 1.60× (2nd cheapest of 20).

Price implies The share price implies a return on equity of about 8.1%; Sichuan Hebang Biotechnology delivers -0.9%, so the price asks more than the business earns today.

Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).

Relative performance

70809010011 May 202611 Aug 20266 Nov 2026Peer median 75603077.SS 69
Six months, rebased to 100: Sichuan Hebang Biotechnology against the median of its 20 peers (local-currency closes).

Sichuan Hebang Biotechnology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥5.78BCN¥7.18BCN¥8.54BCN¥8.76BCN¥12.9B
Revenue growth—-16%-3%-32%—
Gross profitCN¥1.88BCN¥672MCN¥532MCN¥1.88BCN¥5.36B
EBITDAn/aCN¥873MCN¥938MCN¥2.42BCN¥5.42B
Net income-CN¥176M-CN¥536MCN¥31.5MCN¥1.28BCN¥3.81B
Free cash flow-CN¥523M-CN¥181M-CN¥646M-CN¥628MCN¥1.71B
Capital expenditureCN¥1.69BCN¥1.26BCN¥1.12BCN¥829MCN¥936M
Total debtCN¥9.15BCN¥8.71BCN¥8.72BCN¥2.30BCN¥1.93B

Quarterly statements and history in the cockpit →

Sichuan Hebang Biotechnology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%-20%-10%0%+10%000155000902301035002539600486002312002258SMG600596SUMICHEMTATACHEMATUL000422BAYERCROPPARADEEPDEEPAKFERT1866DNL002170UPL603077.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Sichuan Hebang Biotechnology is the large dot.

Fundamentals: return on equity against price-to-book

-10%0%10%20%20×40×000155000902301035002539600486002312002258600596SUMICHEMTATACHEMATULBAYERCROP1866002170UPL603077.SSReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Sichuan Hebang Biotechnology is the large dot.

Capital: ROE delivered against the ROE the price implies

0%20%40%0%20%40%000155000902301035002539002312002258600596SUMICHEMATULBAYERCROPPARADEEP1866DNL002170UPL603077.SSROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Sichuan Hebang Biotechnology is the large dot.

Sichuan Hebang Biotechnology competitors and peer comparison

Head to head with its named competitors (603077.SS vs 600596.SS vs 600409.SS vs 000822.SZ)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Sichuan Hebang Biotechnology 603077.SS$2.59B-30%-24%-1%0.89×8.1%
Zhejiang Xinan Chemical Industrial 600596.SS$1.75B-31%+5%2%0.93×11.6%
Tangshan Sanyou Chemical Industries 600409.SS$1.72B-28%+1%2%0.82×8.9%
Shandong Haihua 000822.SZ$509M-36%-10%-37%1.02×7.8%
Hubei Xingfa Chemicals 600141.SS$4.19B-27%+4%6%1.12×14.8%
Nantong Jiangshan Agrochemical & Chemicals 600389.SS$1.04B-44%+13%10%1.60×12.4%

How Sichuan Hebang Biotechnology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Sichuan Hebang Biotechnology against its 20 peers (data as of 6 Nov 2026)
Measure603077.SSPeer medianRank in peer set
1-month return-5.9%-8.3%10th highest of 21
6-month return-30.4%-25.1%7th lowest of 21
Return on equity-0.9%11.0%3rd lowest of 20
Price / book0.89×1.60×2nd cheapest of 20
ROE the price implies8.1%15.6%least demanding of 20
ROE delivered-0.9%11.0%2nd lowest of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Sichuan Hebang Biotechnology 603077.SSChina$2.59B-30%-24%-1%0.89×8.1%-0.9%
Sichuan New Energy Power 000155.SZChina$2.54B-47%+98%7%1.60×16.0%7.0%
YONFER Agricultural Technology 000902.SZChina$2.69B-2%+15%13%1.48×8.5%13.2%
Shandong Weifang Rainbow Chemical 301035.SZChina$2.42B-32%+6%12%2.11×19.1%11.6%
Chengdu Wintrue 002539.SZChina$2.09B-24%+6%11%1.41×12.0%10.7%
Jiangsu Yangnong Chemical 600486.SSChina$3.42B-22%+3%11%1.87×14.3%11.0%
Sichuan Development Lomon 002312.SZChina$1.93B-36%+5%-2%1.44×15.6%-2.1%
Lier Chemical 002258.SZChina$1.85B+20%+6%6%1.53×11.6%5.6%
Scotts Miracle-Gro SMGUnited States$3.77B+6%-4%n/an/an/an/a
Zhejiang Xinan Chemical Industrial 600596.SSChina$1.75B-31%+5%2%0.93×11.6%2.1%
Sumitomo Chemical India SUMICHEM.NSIndia$1.74B-34%-3%16%4.44×42.6%16.2%
Tata Chemicals TATACHEM.NSIndia$1.64B-25%+2%-9%0.73×14.0%n/a
Atul ATUL.NSIndia$1.63B-26%+18%12%2.34×29.8%12.3%
Hubei Yihua Chemical Industry 000422.SZChina$1.60B-42%+15%5%1.34×13.4%4.8%
Bayer Cropscience India BAYERCROP.NSIndia$1.58B-28%-5%24%4.68×51.8%23.6%
Paradeep Phosphates PARADEEP.NSIndia$1.57B+12%+31%13%2.07×27.0%12.5%
Deepak Fertilisers and Petrochemicals DEEPAKFERT.NSIndia$1.54B-14%+14%11%2.13×34.8%n/a
China XLX Fertiliser 1866.HKHong Kong$1.51B-27%+24%12%0.95×8.1%12.4%
Dyno Nobel DNL.AXAustralia$4.64B+6%-17%6%1.66×13.8%5.8%
Shenzhen Batian Ecological Technique 002170.SZChina$1.44B-29%+3%23%2.60×17.9%23.0%
UPL UPL.NSIndia$4.78B-18%+10%6%1.30×20.2%5.7%

Questions

Who are Sichuan Hebang Biotechnology's main competitors?
Named competitors: Zhejiang Xinan Chemical (600596.SS), Tangshan Sanyou Chemical Industries (600409.SS), Shandong Haihua (000822.SZ), Hubei Xingfa Chemicals (600141.SS), Jiangshan Agrochemical & Chemical (600389.SS). The cockpit's measured peer set (industry) also includes Sichuan New Energy Power (000155.SZ), YONFER Agricultural Technology (000902.SZ), Shandong Weifang Rainbow Chemical (301035.SZ), Chengdu Wintrue (002539.SZ), Jiangsu Yangnong Chemical (600486.SS), Sichuan Development Lomon (002312.SZ).
Is Sichuan Hebang Biotechnology expensive compared with its peers?
On price / book it trades at 0.89× against a peer median of 1.60×, 2nd cheapest of 20 in its peer set. The share price implies a return on equity of about 8.1%; Sichuan Hebang Biotechnology delivers -0.9%, so the price asks more than the business earns today.
How has Sichuan Hebang Biotechnology stock performed?
Over six months to 6 Nov 2026 the shares returned -30.4% against -25.1% for the median peer; over one year -2.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.